Centrus Reports First Quarter 2022 Results
Centrus Energy Corp. (LEU) reported a net loss of $0.4 million for Q1 2022, down from a net income of $5.1 million in Q1 2021. Total revenue fell to $35.3 million, compared to $55.6 million in the same period last year, with a significant decrease of $20.4 million in the LEU segment. Gross profit was $6.3 million, down from $11.7 million year-over-year. However, the company continues to meet milestones under its DOE HALEU contract and seeks to expand its production capabilities at the Piketon facility to enhance domestic uranium enrichment.
- Long-term order book valued at $1 billion as of March 31, 2022.
- Revenue from uranium sales increased to $4.9 million in Q1 2022, compared to no sales in Q1 2021.
- Centrus continues to meet all milestones under the DOE HALEU contract.
- Net loss of $0.4 million in Q1 2022 compared to net income of $5.1 million in Q1 2021.
- Total revenue decreased by $20.3 million year-over-year.
- Gross profit declined to $6.3 million from $11.7 million year-over-year.
Financial Highlights
- Gross profit of
$6.3 million - Net loss of
$0.4 million on$35.3 million in revenue - Consolidated cash balance of
$168.5 million as of March 31, 2022 - Long-term order book valued at
$1 billion as of March 31, 2022
Business Highlights
- Continued to meet all milestones under the DOE HALEU contract
- Completed conceptual design for commercial-scale HALEU cascade
BETHESDA, Md., May 5, 2022 /PRNewswire/ -- Centrus Energy Corp. (NYSE American: LEU) today reported a net loss of
"Our first quarter results reflect the quarter-to-quarter lumpiness in our revenues and margins that we discuss in our earnings call each quarter and do not reflect our annual performance -- and we continue to see strong opportunities for our future," said Daniel B. Poneman, Centrus President and Chief Executive Officer. "The unfolding tragedy in Ukraine has catalyzed the nuclear fuel marketplace and highlighted the urgent need for a robust public and private-sector response and investment in domestic uranium enrichment capacity so that we are no longer dependent upon foreign imports. With the only US-owned enrichment technology and a Nuclear Regulatory Commission license to produce High-Assay, Low-Enriched Uranium production as well as Low Enriched Uranium, Centrus is well-positioned to lead the crucial effort to bolster energy security for the current and next generation fleet of reactors."
Centrus generated total revenue of
Revenue from the technical solutions segment had a slight increase of
Cost of sales for the LEU segment decreased
Cost of sales for the technical solutions segment decreased
Centrus realized a gross profit of
Selling, general and administrative expenses decreased by
Net loss was
Centrus continues to meet all milestones under the HALEU contract to date and expects to compete for additional funding as part of an upcoming contract to demonstrate and operate the HALEU cascade; the Department of Energy indicated in a February pre-solicitation notice that it intends to issue a solicitation soon.
In addition, Centrus recently completed conceptual design for a commercial-scale HALEU cascade that would have 120 centrifuges and a much larger output than the 16-centrifuge demonstration cascade. Each 120-machine commercial cascade could produce approximately 6 metric tons of HALEU per year. Subject to the availability of funding and/or offtake agreements, Centrus' could scale up the Piketon facility to accommodate whatever level of HALEU production is required and could also produce Low-Enriched Uranium for existing reactors if needed. The Piketon facility is large enough to accommodate thousands of centrifuges.
Centrus Energy is a trusted supplier of nuclear fuel and services for the nuclear power industry. Centrus provides value to its utility customers through the reliability and diversity of its supply sources – helping them meet the growing need for clean, affordable, carbon-free electricity. Since 1998, the Company has provided its utility customers with more than 1,750 reactor years of fuel, which is equivalent to 7 billion tons of coal. With world-class technical and engineering capabilities, Centrus is also advancing the next generation of centrifuge technologies so that America can restore its domestic uranium enrichment capability in the future. Find out more at www.centrusenergy.com.
Forward-Looking Statements:
This news release contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934. In this context, forward-looking statements mean statements related to future events, may address our expected future business and financial performance, and often contain words such as "expects", "anticipates", "intends", "plans", "believes", "will", "should", "could", "would" or "may" and other words of similar meaning. Forward-looking statements by their nature address matters that are, to different degrees, uncertain.
For Centrus Energy Corp., particular risks and uncertainties that could cause our actual future results to differ materially from those expressed in our forward-looking statements include but are not limited to the following which are, and will be, exacerbated by the novel coronavirus ("COVID-19") pandemic and subsequent variants, and any worsening of the global business and economic environment as a result; risks related to the war in Ukraine and geopolitical conflicts and the imposition of sanctions or other measures that could impact our ability to obtain or sell low enriched uranium ("LEU") under our existing supply contract with the Russian government-owned entity TENEX, Joint-Stock Company ("TENEX"); risks related to the refusal of TENEX to deliver LEU to us if TENEX is unable to identify an unsanctioned bank to which we can send payments for the separative work units ("SWU") contained in the LEU, or to make other payments under our supply contract with TENEX; risks related to natural and other disasters, including the continued impact of the March 2011 earthquake and tsunami in Japan on the nuclear industry and on our business, results of operations and prospects; risks related to financial difficulties experienced by customers or suppliers, including possible bankruptcies, insolvencies or any other inability to pay for our products or services or delays in making timely payment; risks related to pandemics and other health crises, the impact and potential extended duration of the current supply/demand imbalance in the market for LEU; risks related to our ability to sell the LEU we procure pursuant to our purchase obligations under our supply agreements including those imposed under the 1992 Russian Suspension Agreement as amended, international trade legislation and other international trade restrictions; risks related to existing or new trade barriers and contract terms that limit our ability to procure LEU for, or deliver LEU to customers; pricing trends and demand in the uranium and enrichment markets and their impact on our profitability; risks related to the movement and timing of customer orders; risks related to our dependence on others, such as our transporters, for deliveries of LEU including deliveries from TENEX, under our commercial supply agreement with TENEX and deliveries under our long-term commercial supply agreement with Orano Cycle ("Orano"); risks associated with our reliance on third-party suppliers to provide essential products and services to us; risks related to the fact that we face significant competition from major producers who may be less cost sensitive or are wholly or partially government owned; risks that our ability to compete in foreign markets may be limited for various reasons; risks related to the fact that our revenue is largely dependent on our largest customers; risks related to our sales order book, including uncertainty concerning customer actions under current contracts and in future contracting due to market conditions and our lack of current production capability; risks related to whether or when government funding or demand for high-assay low-enriched uranium ("HALEU") for government or commercial uses will materialize; risks and uncertainties regarding funding for continuation and deployment of the American Centrifuge technology; risks related to (i) our ability to perform and absorb costs under our agreement with the U.S. Department of Energy ("DOE") to deploy a cascade of centrifuges to demonstrate production of HALEU for advanced reactors (the "HALEU Contract"), (ii) to obtain contracts and funding to be able to continue operations and (iii) our ability to obtain and/or perform under other agreements; risks that (i) we may not obtain the full benefit of the HALEU Contract and may not be able to operate the HALEU enrichment facility to produce HALEU after the completion of the existing HALEU Contract or (ii) the HALEU enrichment facility may not be available to us as a future source of supply; risks related to uncertainty regarding our ability to commercially deploy competitive enrichment technology; risks related to the potential for further demobilization or termination of our American Centrifuge work; risks that we will not be able to timely complete the work that we are obligated to perform; risks related to our ability to perform fixed-price and cost-share contracts such as the HALEU Contract, including the risk that costs could be higher than expected; risks related to our significant long-term liabilities, including material unfunded defined benefit pension plan obligations and postretirement health and life benefit obligations; risks relating to our
These factors may not constitute all factors that could cause actual results to differ from those discussed in any forward-looking statement. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. Readers are urged to carefully review and consider the various disclosures made in this report and in our other filings with the SEC that attempt to advise interested parties of the risks and factors that may affect our business. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this press release except as required by law.
Contacts:
Investors: Dan Leistikow LeistikowD@centrusenergy.com
Media: Lindsey Geisler GeislerLR@centrusenergy.com
CENTRUS ENERGY CORP.
ADJUSTED NET INCOME PER SHARE RECONCILIATION TABLE
The Company measures Net Income (Loss) and Net Income (Loss) per Share both on a GAAP basis and on an adjusted basis to exclude deemed dividends allocable to retired preferred stock shares ("Adjusted Net Income (Loss)" and "Adjusted Net Income (Loss) per Share"). We believe Adjusted Net Income (Loss) and Adjusted Net Income (Loss) per Share, which are non-GAAP financial measures, provide investors with additional understanding of the Company's financial performance as well as its strategic financial planning analysis and period-to-period comparability. These metrics are useful to investors because they reflect how management evaluates the Company's ongoing operating performance from period-to-period after removing certain transactions and activities that affect comparability of the metrics and are not reflective of the Company's core operations.
Three Months Ended March 31, | |||
2022 | 2021 | ||
Numerator (in millions): | |||
Net income (loss) | $ (0.4) | $ 5.1 | |
Less: Preferred stock dividends - undeclared and cumulative | — | 0.7 | |
Less: Distributed earnings allocable to retired preferred shares | — | 6.6 | |
Net loss allocable to common stockholders | $ (0.4) | $ (2.2) | |
Plus: Distributed earnings allocable to retired preferred shares | $ — | $ 6.6 | |
Adjusted net income (loss), including distributed earnings allocable to retired preferred | $ (0.4) | $ 4.4 | |
Denominator (in thousands): | |||
Average common shares outstanding - basic | 14,547 | 12,818 | |
Average common shares outstanding - diluted (a) | 14,547 | 12,818 | |
Net loss per share (in dollars): | |||
Basic | $ (0.03) | $ (0.17) | |
Diluted | $ (0.03) | $ (0.17) | |
Plus: Effect of distributed earnings allocable to retired preferred shares, per common share (in dollars): | |||
Basic | $ — | $ 0.51 | |
Diluted | $ — | $ 0.50 | |
Adjusted Net Income (Loss) per Share (Non-GAAP) (in dollars): | |||
Basic | $ (0.03) | $ 0.34 | |
Diluted (a) | $ (0.03) | $ 0.33 | |
(a) For purposes of calculating the Adjusted Net Income (Loss) per Share of |
CENTRUS ENERGYCORP | |||
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME | |||
(Unaudited; in millions, except share and per share data)
| |||
Three Months Ended March 31, | |||
2022 | 2021 | ||
Revenue: | |||
Separative work units | $ 12.8 | $ 38.1 | |
Uranium | 4.9 | — | |
Technical solutions | 17.6 | 17.5 | |
Total revenue | 35.3 | 55.6 | |
Cost of Sales: | |||
Separative work units and uranium | 14.8 | 25.4 | |
Technical solutions | 14.2 | 18.5 | |
Total cost of sales | 29.0 | 43.9 | |
Gross profit | 6.3 | 11.7 | |
Advanced technology costs | 1.1 | 0.5 | |
Selling, general and administrative | 7.5 | 8.2 | |
Amortization of intangible assets | 1.1 | 2.1 | |
Operating income (loss) | (3.4) | 0.9 | |
Nonoperating components of net periodic benefit income | (3.3) | (4.3) | |
Income (loss) before income taxes | (0.1) | 5.2 | |
Income tax expense | 0.3 | 0.1 | |
Net income (loss) and comprehensive income (loss) | (0.4) | 5.1 | |
Preferred stock dividends - undeclared and cumulative | — | 0.7 | |
Distributed earnings allocable to retired preferred shares | — | 6.6 | |
Net loss allocable to common stockholders | $ (0.4) | $ (2.2) | |
Net loss per share: | |||
Basic | $ (0.03) | $ (0.17) | |
Diluted | $ (0.03) | $ (0.17) | |
Average number of common shares outstanding (in thousands): | |||
Basic | 14,547 | 12,818 | |
Diluted | 14,547 | 12,818 | |
CENTRUS ENERGYCORP | |||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
(Unaudited; in millions) | |||
Three Months Ended March 31, | |||
2022 | 2021 | ||
OPERATING | |||
Net income (loss) | $ (0.4) | $ 5.1 | |
Adjustments to reconcile net income (loss) to cash used in operating activities: | |||
Depreciation and amortization | 1.3 | 2.2 | |
Accrued loss on long-term contract | (0.5) | (2.0) | |
Deferred tax assets | 0.3 | — | |
Equity related compensation | 0.5 | — | |
Changes in operating assets and liabilities: | |||
Accounts receivable | 16.6 | 14.2 | |
Inventories | 11.1 | (18.7) | |
Inventories owed to customers and suppliers | (8.1) | 8.4 | |
Accounts payable and other liabilities | 1.2 | 6.6 | |
Payables under inventory purchase agreements | (28.3) | (4.4) | |
Deferred revenue and advances from customers, net of deferred costs | (0.3) | (12.5) | |
Pension and postretirement benefit liabilities | (5.1) | (7.4) | |
Other, net | (0.9) | — | |
Cash used in operating activities | (12.6) | (8.5) | |
INVESTING | |||
Capital expenditures | (0.1) | (0.4) | |
Cash used in investing activities | (0.1) | (0.4) | |
FINANCING | |||
Proceeds from the issuance of common stock, net | — | 23.2 | |
Exercise of stock options | 0.2 | 0.2 | |
Payment of interest classified as debt | (3.1) | (3.1) | |
Other | (0.3) | (0.1) | |
Cash provided by (used in) financing activities | (3.2) | 20.2 | |
Increase (decrease) in cash, cash equivalents and restricted cash | (15.9) | 11.3 | |
Cash, cash equivalents and restricted cash, beginning of period (Note 3) | 196.8 | 157.9 | |
Cash, cash equivalents and restricted cash, end of period (Note 3) | $ 180.9 | $ 169.2 | |
Non-cash activities: | |||
Common stock and warrant issued in exchange for preferred stock | $ — | $ 7.5 | |
Reclassification of stock-based compensation liability to equity | $ 10.6 | $ 7.5 | |
Property, plant and equipment included in accounts payable and accrued liabilities | $ 0.2 | $ 0.1 | |
Equity issuance costs included in accounts payable and accrued liabilities | $ — | $ 0.4 | |
Shares withheld for employee taxes | $ 1.9 | $ — | |
CENTRUS ENERGY CORP. | |||
CONSOLIDATED BALANCE SHEETS | |||
(Unaudited; in millions, except share and per share data) | |||
March 31, | December 31, | ||
ASSETS | |||
Current assets: | |||
Cash and cash equivalents | $ 168.5 | $ 193.8 | |
Accounts receivable | 12.5 | 29.1 | |
Inventories | 89.4 | 91.1 | |
Deferred costs associated with deferred revenue | 143.3 | 143.3 | |
Other current assets | 9.4 | 8.6 | |
Total current assets | 423.1 | 465.9 | |
Property, plant and equipment, net of accumulated depreciation of | 5.5 | 5.3 | |
Deposits for financial assurance | 12.2 | 2.8 | |
Intangible assets, net | 53.6 | 54.7 | |
Deferred tax assets | 41.2 | 41.4 | |
Other long-term assets | 2.0 | 2.3 | |
Total assets | $ 537.6 | $ 572.4 | |
LIABILITIES AND STOCKHOLDERS' DEFICIT | |||
Current liabilities: | |||
Accounts payable and accrued liabilities | $ 33.7 | $ 37.8 | |
Payables under inventory purchase agreements | 9.6 | 37.9 | |
Inventories owed to customers and suppliers | 0.3 | 8.4 | |
Deferred revenue and advances from customers | 302.8 | 303.1 | |
Current debt | 6.1 | 6.1 | |
Total current liabilities | 352.5 | 393.3 | |
Long-term debt | 98.8 | 101.8 | |
Postretirement health and life benefit obligations | 113.5 | 114.9 | |
Pension benefit liabilities | 19.6 | 23.1 | |
Advances from customers | 45.1 | 45.1 | |
Long-term inventory loan | 31.8 | 22.4 | |
Other long-term liabilities | 9.3 | 13.7 | |
Total liabilities | 670.6 | 714.3 | |
Commitments and contingencies | |||
Stockholders' deficit: | |||
Preferred stock, par value | |||
Series A Participating Cumulative Preferred Stock, none issued | — | — | |
Series B Senior Preferred Stock, none issued | — | — | |
Class A Common Stock, par value | 1.4 | 1.4 | |
Class B Common Stock, par value | 0.1 | 0.1 | |
Excess of capital over par value | 150.1 | 140.7 | |
Accumulated deficit | (285.0) | (284.6) | |
Accumulated other comprehensive income, net of tax | 0.4 | 0.5 | |
Total stockholders' deficit | (133.0) | (141.9) | |
Total liabilities and stockholders' deficit | $ 537.6 | $ 572.4 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/centrus-reports-first-quarter-2022-results-301541308.html
SOURCE Centrus Energy Corp.
FAQ
What were Centrus Energy's revenues for Q1 2022?
How much did Centrus Energy lose in Q1 2022?
What is the status of Centrus Energy's HALEU contract?
What is the gross profit of Centrus Energy for Q1 2022?
How does Centrus Energy's Q1 2022 performance compare to Q1 2021?
